Skip to main content
SpringerLink
Log in
Book cover

The Kidney pp 199–206Cite as

Nonneoplastic Kidney Diseases in the Setting of a Renal Mass

  • Chapter

  • 2606 Accesses

Abstract

Early detection has led to significant gains in cancer-free survival rates for kidney cancer patients, and the preservation of renal function has emerged as an important objective. Diabetes and hypertension are important independent risk factors for the development of renal cell carcinoma, so the corresponding diabetic and/or hypertensive kidney injuries are commonly encountered. With the number of kidney cancer survivors approaching 350,000 in the USA, further gains in the clinical outcomes for kidney cancer can be achieved with additional attention on the harmful impact of nonneoplastic kidney diseases and improved coordination between urologists, nephrologists, and pathologists during the management of these patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

CKD:

Chronic kidney disease

EM:

Electron microscopy

FSGS:

Focal segmental glomerulosclerosis

IF:

Immunofluorescence

NSS:

Nephron-sparing surgery

RCC:

Renal cell carcinoma

RN:

Radical nephrectomy

PN:

Partial nephrectomy

TMA:

Thrombotic microangiopathy

References

  1. Patard J-J. Incidental renal tumours. Curr Opin Urol. 2009;19(5):454–8.

    Article  PubMed  Google Scholar 

  2. Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Pummer K, et al. Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival. Int Urol Nephrol. 2012;44(4):997–1004.

    Article  PubMed  Google Scholar 

  3. Lau WKO, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75(12):1236–42.

    Article  CAS  PubMed  Google Scholar 

  4. Tan H-J, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. J Am Med Assoc. 2012;307(15):1629–35.

    Article  CAS  Google Scholar 

  5. Jewett MAS, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60(1):39–44.

    Article  PubMed  Google Scholar 

  6. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.

    Article  PubMed  Google Scholar 

  7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.

    Article  CAS  PubMed  Google Scholar 

  8. The National Kidney Foundation: News [Internet]. http://www.kidney.org/news/newsroom/factsheets/FastFacts.cfm. Cited 31 Jan 2014.

  9. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–40.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Rifkin DE. Doctors without metaphors. Am J Kidney Dis. 2009;54(5):A35–6.

    Article  PubMed  Google Scholar 

  11. Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002;61(6):2201–9.

    Article  PubMed  Google Scholar 

  12. Lowrance WT, Ordoñez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014;25(10):2327–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1–150.

    Article  Google Scholar 

  14. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.

    Article  PubMed  Google Scholar 

  15. Henriksen KJ, Meehan SM, Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol. 2007;31(11):1703–8.

    Article  PubMed  Google Scholar 

  16. Salvatore SP, Cha EK, Rosoff JS, Seshan SV. Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Arch Pathol Lab Med. 2013;137(4):531–40.

    Article  CAS  PubMed  Google Scholar 

  17. Srigley JR, Amin MB, Delahunt B, Campbell SC, Chang A, Grignon DJ, et al. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med. 2010;134(4):e25–30.

    PubMed  Google Scholar 

  18. Algaba F, Delahunt B, Berney DM, Camparo P, Compérat E, Griffiths D, et al. Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. J Clin Pathol. 2012;65(2):106–13.

    Article  PubMed  Google Scholar 

  19. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D’Agati VD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70(12):2148–51.

    CAS  PubMed  Google Scholar 

  20. Van der Ven K, Nguyen TQ, Goldschmeding R. Immunofluorescence on proteinase XXIV-digested paraffin sections. Kidney Int. 2007;72(7):896.

    PubMed  Google Scholar 

  21. Nasr SH, Markowitz GS, Valeri AM, Yu Z, Chen L, D’Agati VD. Thin basement membrane nephropathy cannot be diagnosed reliably in deparaffinized, formalin-fixed tissue. Nephrol Dial Transplant. 2007;22(4):1228–32.

    Article  PubMed  Google Scholar 

  22. Bonsib SM, Pei Y. The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important? Adv Anat Pathol. 2010;17(4):235–50.

    Article  PubMed  Google Scholar 

  23. Zucchetto A, Dal Maso L, Tavani A, Montella M, Ramazzotti V, Talamini R, et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol. 2007;18(3):596–600.

    Article  CAS  PubMed  Google Scholar 

  24. Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nosé V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30(5):575–84.

    Article  PubMed  Google Scholar 

  25. Markowitz GS, Lin J, Valeri AM, Avila C, Nasr SH, D’Agati VD. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2002;33(8):826–35.

    Article  PubMed  Google Scholar 

  26. Chow WH, Gridley G, Fraumeni JF, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305–11.

    Article  CAS  PubMed  Google Scholar 

  27. Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67(2):647–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Chicago Medical Center, 5841 S. Maryland Ave, Chicago, IL, 60637, USA

    Anthony Chang M.D.

  2. Department of Pathology, Brigham and Women’s Hospital, Boston, MA, 02115, USA

    Vanesa Bijol M.D.

Authors
  1. Anthony Chang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanesa Bijol M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Chang M.D. .

Editor information

Editors and Affiliations

  1. Department of Pathology, University of California at San Diego Department of Pathology, San Diego, California, USA

    Donna E. Hansel

  2. Department of Urology, University of California at San Diego Department of Urology, San Diego, California, USA

    Christopher J. Kane

  3. Department of Pathology and Surgery, University of Chicago, Chicago, Illinois, USA

    Gladell P. Paner

  4. Department of Urologic Surgery, Vanderbilt University Medical Center Department of Urologic Surgery, Nashville, Tennessee, USA

    Sam S. Chang

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chang, A., Bijol, V. (2016). Nonneoplastic Kidney Diseases in the Setting of a Renal Mass. In: Hansel, D., Kane, C., Paner, G., Chang, S. (eds) The Kidney. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3286-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3286-3_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3285-6

  • Online ISBN: 978-1-4939-3286-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation